ReviewTranslational andrology and urology2026
Testicular microcirculation dysfunction-induced Sertoli cell injury-exosome therapy as a novel restorative strategy: a narrative review.
Review in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Testicular microcirculation disorders, arising from systemic or local factors, have increasingly been recognized for their detrimental impact on male reproductive health. Sertoli cells are essential for maintaining the spermatogenic microenvironment, constructing the blood-testis barrier, and supporting spermatogenic cell proliferation. Dysfunction of Sertoli cells is a major contributor to testicular dysfunction and male infertility. This review aims to elucidate how testicular microcirculation disorders impair Sertoli cell function and to explore the potential of exosome-based therapies in restoring Sertoli cell function. Methods: A narrative literature search of PubMed and Web of Science was conducted up to August 25, 2026, to identify relevant publications on testicular microcirculation, Sertoli cell dysfunction, and exosome-based therapeutic strategies. Selected articles were reviewed and synthesized narratively. Key Content and Findings: Testicular microcirculation disorders impair Sertoli cell function primarily through oxidative stress, disruption of the internal microenvironment, and endocrine/paracrine imbalances. These pathological processes collectively damage male reproductive health. In recent years, exosome-based technologies have shown significant promise in restoring Sertoli cell function. Specifically, exosomes derived from Sertoli cells or mesenchymal stem cells can protect and enhance Sertoli cell function by mediating intercellular communication and delivering bioactive molecules. Conclusions: This review provides an in-depth analysis of the mechanisms linking testicular microcirculation disorders to Sertoli cell dysfunction and highlights the therapeutic potential of exosome technologies. These findings offer new insights and approaches for the treatment and prevention of male reproductive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.